Brief: JCR Says Acumen Exercises Exclusive Option For Up To Two Alzheimer's Candidates
17/06/2026 19:00
BRIEF-JCR Says Acumen Exercises Exclusive Option For Up To Two Alzheimer's Candidates June 17 (Reuters) - JCR Pharmaceuticals Co Ltd 4552.T:
JCR PHARMACEUTICALS CO - ACUMEN PHARMACEUTICALS EXERCISES EXCLUSIVE OPTION FOR UP TO TWO ALZHEIMER'S DISEASE CANDIDATES WITH JCR
JCR PHARMACEUTICALS CO - ACUMEN'S EBD PROGRAM ON TRACK FOR IND FILING IN MID-2027
JCR PHARMACEUTICALS CO - ELIGIBLE FOR UP TO $555 MILLION IN MILESTONE PAYMENTS FROM ACUMEN DEAL
JCR PHARMACEUTICALS CO - TO RECEIVE TIERED ROYALTIES ON NET SALES FROM COLLABORATION PRODUCTS
Source text: ID:nBw2fND6ra
Further company coverage: 4552.T
((Reuters.Briefs@thomsonreuters.com;))